Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292680837> ?p ?o ?g. }
- W4292680837 endingPage "103795" @default.
- W4292680837 startingPage "103795" @default.
- W4292680837 abstract "Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy is the standard treatment for patients with muscle-invasive bladder cancer (MIBC). However, the implementation of NAC is lower than desirable mainly due to its limited impact on overall survival, patients' comorbidities and the lack of predictive biomarkers to select those patients most likely to benefit from NAC. In the last decade, improved molecular MIBC characterisation, the identification of potential predictive and prognostic biomarkers as well as the incorporation of new effective therapies with a better toxicity profile, such as immunotherapy, has changed the treatment paradigm for MIBC. Therefore, the main goal for the near future is to introduce these clinical and translational advances into routine clinical practice to personalise treatment for each patient and increase the opportunity to implement bladder preservation strategies. The present review focuses on the current status of NAC in MIBC, unsolved questions and future therapeutic approaches." @default.
- W4292680837 created "2022-08-23" @default.
- W4292680837 creator A5017537885 @default.
- W4292680837 creator A5059722373 @default.
- W4292680837 creator A5060467306 @default.
- W4292680837 creator A5079984186 @default.
- W4292680837 date "2022-10-01" @default.
- W4292680837 modified "2023-10-08" @default.
- W4292680837 title "Neoadjuvant therapy for muscle-invasive bladder cancer: Current clinical scenario, future perspectives, and unsolved questions" @default.
- W4292680837 cites W1560239325 @default.
- W4292680837 cites W1576738591 @default.
- W4292680837 cites W1771287927 @default.
- W4292680837 cites W1893588230 @default.
- W4292680837 cites W1903272704 @default.
- W4292680837 cites W1964037817 @default.
- W4292680837 cites W1975918912 @default.
- W4292680837 cites W1989141974 @default.
- W4292680837 cites W2010464208 @default.
- W4292680837 cites W2029132015 @default.
- W4292680837 cites W2033775272 @default.
- W4292680837 cites W2047905289 @default.
- W4292680837 cites W2068523052 @default.
- W4292680837 cites W2103561213 @default.
- W4292680837 cites W2103725052 @default.
- W4292680837 cites W2113156769 @default.
- W4292680837 cites W2131178190 @default.
- W4292680837 cites W2144496751 @default.
- W4292680837 cites W2147180151 @default.
- W4292680837 cites W2151278059 @default.
- W4292680837 cites W2160107406 @default.
- W4292680837 cites W2160553230 @default.
- W4292680837 cites W2164791945 @default.
- W4292680837 cites W2168846224 @default.
- W4292680837 cites W2332342311 @default.
- W4292680837 cites W2432541865 @default.
- W4292680837 cites W2604535399 @default.
- W4292680837 cites W2619249519 @default.
- W4292680837 cites W2738951134 @default.
- W4292680837 cites W2763670669 @default.
- W4292680837 cites W2785803176 @default.
- W4292680837 cites W2809550065 @default.
- W4292680837 cites W2888969259 @default.
- W4292680837 cites W2889397974 @default.
- W4292680837 cites W2889646458 @default.
- W4292680837 cites W2893208123 @default.
- W4292680837 cites W2895579856 @default.
- W4292680837 cites W2902919059 @default.
- W4292680837 cites W2910189873 @default.
- W4292680837 cites W2911188335 @default.
- W4292680837 cites W2944318130 @default.
- W4292680837 cites W2947456133 @default.
- W4292680837 cites W2972475028 @default.
- W4292680837 cites W2975497362 @default.
- W4292680837 cites W2981454286 @default.
- W4292680837 cites W2983607390 @default.
- W4292680837 cites W2987436342 @default.
- W4292680837 cites W2991794716 @default.
- W4292680837 cites W2995340453 @default.
- W4292680837 cites W2995899912 @default.
- W4292680837 cites W3004971171 @default.
- W4292680837 cites W3006222801 @default.
- W4292680837 cites W3009271488 @default.
- W4292680837 cites W3009770484 @default.
- W4292680837 cites W3011938621 @default.
- W4292680837 cites W3015451486 @default.
- W4292680837 cites W3036685272 @default.
- W4292680837 cites W3039008316 @default.
- W4292680837 cites W3048767892 @default.
- W4292680837 cites W3049755614 @default.
- W4292680837 cites W3081622691 @default.
- W4292680837 cites W3088018720 @default.
- W4292680837 cites W3088168604 @default.
- W4292680837 cites W3092138236 @default.
- W4292680837 cites W3092302767 @default.
- W4292680837 cites W3096521890 @default.
- W4292680837 cites W3118434887 @default.
- W4292680837 cites W3135321607 @default.
- W4292680837 cites W3164582383 @default.
- W4292680837 cites W3192058930 @default.
- W4292680837 cites W3207952631 @default.
- W4292680837 cites W4211115520 @default.
- W4292680837 cites W4220657944 @default.
- W4292680837 cites W4224101922 @default.
- W4292680837 cites W4226070359 @default.
- W4292680837 doi "https://doi.org/10.1016/j.critrevonc.2022.103795" @default.
- W4292680837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35988856" @default.
- W4292680837 hasPublicationYear "2022" @default.
- W4292680837 type Work @default.
- W4292680837 citedByCount "1" @default.
- W4292680837 countsByYear W42926808372023 @default.
- W4292680837 crossrefType "journal-article" @default.
- W4292680837 hasAuthorship W4292680837A5017537885 @default.
- W4292680837 hasAuthorship W4292680837A5059722373 @default.
- W4292680837 hasAuthorship W4292680837A5060467306 @default.
- W4292680837 hasAuthorship W4292680837A5079984186 @default.
- W4292680837 hasConcept C121608353 @default.
- W4292680837 hasConcept C126322002 @default.
- W4292680837 hasConcept C143998085 @default.